PEAR1相关论文
目的 为了探讨在阿司匹林个体化治疗中,血栓弹力图中AA抑制率与PEAR1(rs12041331)和GP1BA(rs6065)基因多态性是否具有相关性.方法 ......
背景阿司匹林具有良好的抗血小板作用,很多复发脑梗死患者已经在使用阿司匹林进行抗血小板治疗,但对阿司匹林反应的个体差异很大,......
Identification of PEAR1 single-nucleotide polymorphisms and their influences on the variation in Pra
Aim: The platelet responses to antiplatelet drugs are highly variable.However,the associated mechanisms are poorly defin......
Objective: To explore the correlation between PEAR1 genetic polymorphism and PTE.Material and methods: The variant loci ......
目的:替格瑞洛是首个直接、可逆的血小板膜P2Y12受体拮抗剂,主要由CYP3A4代谢为活性代谢产物.血小板内皮聚集受体1 (platelet endo......
目的:探讨GPⅢа PLA2、PEAR1、PTGS1基因多态性与阿司匹林临床抗血栓疗效的相关性.方法:回顾性筛选我院2015年1月 – 2016年5月诊......
,Associations of MDR1, TBXA2R, PLA2G7, and PEAR1 genetic polymorphisms with the platelet activity in
...
目的:分析广东河源地区缺血性脑梗死患者GPⅢa、PEAR1、PTGS1、GSTP1基因多态性特点,以利于指导用药,精确化治疗,做好脑血管病一级......
背景氯吡格雷和阿司匹林是临床上常用的抗血小板聚集药物,二者联合应用是经皮冠状动脉介入治疗(Percutaneous coronary interventi......
目的探讨缺血性脑卒中患者阿司匹林反应与血小板内皮聚集受体1(platelet endothelial aggregation receptor1,PEAR1)基因多态性的......
目的:探讨PEAR1基因多态性与肺血栓栓塞症发病遗传的相关性。方法:通过全基因外显子组测序和第一代Sanger测序分别筛查和确认1个肺......
目的探讨血小板内皮聚集受体1（platelet endothelial aggregation receptor1，PEAR1）基因多态性与脑梗死患者长期服用阿司匹林复发的相......
